• Home
  • NEWS
  • Event

Event

合計 39件
検索

検索

썸네일
2025 1st NEXEL INNOVATION TALK. New Era of Organoid     기조 강연 · 주식회사 넥셀 · 부사장 우동훈 "Organoids: From the Laboratory to the Real World"     Session 1-1 · 주식회사 넥셀 · 박사 황선인 Cardiac Organoids as Translational Models: From Generation to Disease Modeling and Standardization     Session 1-2 · 국가독성과학연구소 · 박사 박한진 Development and application of hPSC-derived liver organoid models for drug and chemical safety assessment     Session 2-1 · 한국뇌연구원 · 박사 김범수 Brain Cell-Specific Fluorescent Small Molecular Probes: A Novel Method for the Functional Analysis of Human Brain Organoids     Session 2-2 · 고려대학교 · 교수 임경태 Development of robust, efficient, scalable iPSC-derived lung organoid models
썸네일
The 48th Workshop of The Korean Society of Non-Clinical Study (KSNS).   NEXEL is excited to participate in the 48th Workshop of the Korean Society of Non-Clinical Study (KSNS), taking place at JEJU ICC!   Visit us at Booth #41 to explore the latest advancements in iPSC-based non-clinical testing and human-relevant research models.   As a leader in iPSC-derived technologies and next-generation NAMs (New Approach Methodologies), NEXEL is committed to transforming non-clinical research through innovation and collaboration.   At KSNS, we’ll be showcasing our comprehensive portfolio of: • hiPSC-derived cell and organoid platforms • Cardio-safety analysis services • Customized CDMO solutions — all designed to bridge the gap between non-clinical and clinical research.   If you’re attending the KSNS Workshop, we’d love to meet you!   Let’s discuss how NEXEL’s technologies can empower The Preeminent Clinical Studies from Distinguished Non-clinical Researches and accelerate your R&D goals.   ≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡   In the midst of a global economic paradigm shift and the revolution of knowledge and light, our society has entered a new era of communication and innovation. Even under unprecedented circumstances, our unwavering passion for new drug development has led to The Preeminent Clinical Studies from Distinguished Non-clinical Researches (青出於藍 靑於藍).   We are pleased to invite you to the 48th Workshop of the Korean Society of Toxicology, a gathering to celebrate and share our collective progress.   This year’s workshop is designed to provide a comprehensive overview of the latest trends and practical strategies in drug development.   Session 1 will explore new directions in global and domestic R&D strategies for Alzheimer’s disease therapeutics, focusing on innovative biotech platforms.   Session 2 will discuss translational approaches from non-clinical to clinical research, featuring case studies in MASH treatments, OX40L/TNFa agonists, immunocytokines, and rare disease therapeutics.   Sessions 3 & 4 will cover AI-driven drug discovery, biomarker strategies from the clinical researcher’s perspective, and CAR-T/Bispecific Ab–TPD-based modalities, encompassing both conceptual and practical insights for next-generation drug development.   Session 5 will highlight Althera’s ALT-B4 and VUNO’s VX-149 (Unafra®) case studies, emphasizing the transition from biologics to NDA success strategies. The Young Scientist Award will recognize the passion and growth of emerging researchers, while the T2B Satellite Session will share outcomes and future directions of translational research connecting bench to bedside.   Following the Dinner Seminar, a dedicated Social Networking Session will provide an opportunity for participants to exchange ideas, recognize each other’s efforts, and strengthen collaboration beyond the boundaries of their busy schedules.   This workshop also marks the conclusion of the 17th term of our Clinical Committee — a meaningful moment to reflect on the past two years of progress and to prepare for a renewed start with our valued members and colleagues. We extend our sincere gratitude for your continued passion and support, and we look forward to an inspiring gathering in Jeju this year.  
썸네일
2025 SPS Annual Meeting.   NEXEL is heading to the SPS 2025 Annual Meeting!   Join us at the premier global conference for safety pharmacology, where scientists, regulators, and industry leaders gather to advance the science and practice of evaluating the safety of new drugs and chemicals.   As a pioneer in iPSC-based technologies and next-generation non-clinical testing, NEXEL will showcase: iPSC-derived cell products Cardio-safety analysis services Customized CDMO solutions   We’re redefining drug discovery and safety testing with human-relevant, animal-free models—enabling faster, safer, and more ethical innovation.   Visit us at Booth #213 to explore how NEXEL can empower your research and drive progress in the field of safety pharmacology.   ≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡   The Safety Pharmacology Society Annual Meeting is a must-attend event for anyone interested in drug discovery and the field of safety pharmacology.   This conference brings together experts from around the world to share the latest research and knowledge on the evaluation of the safety of new drugs and chemicals.   Attendees will have the opportunity to learn from renowned scientists, participate in educational sessions, and network with peers and leaders in the field.   Whether you are a seasoned professional or a student just starting out, the Safety Pharmacology Society Annual Meeting is an excellent opportunity to expand your knowledge and enhance your career in the field of safety pharmacology.  
썸네일
The 22nd 2025 KSAAE Annual Meeting.   NEXEL is heading to the KSAAE 2025 Annual Meeting at BPEX in Busan, Korea!   Join us at Korea’s leading conference on alternatives to animal testing, where researchers, regulators, and innovators come together to shape the future of ethical and human-relevant science.   As a pioneer in iPSC-based technologies and next-generation non-clinical testing, NEXEL will showcase: - iPSC-derived cell products - Cardio-safety analysis services - Customized CDMO solutions   We’re redefining drug discovery and safety testing with animal-free, human-relevant models—enabling faster, safer, and more ethical innovation.   Visit us at Booth #5 & #6 to explore how NEXEL can empower your research and advance non-animal methodologies (NAMs).   ≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡   The Korean Society for Alternatives to Animal Experiments (KSAAE) is a leading academic organization dedicated to promoting the development, validation, and implementation of alternative methods to animal testing in Korea.   Since its establishment, KSAAE has played a key role in advancing the 3Rs principles—Replacement, Reduction, and Refinement—within scientific research, regulatory toxicology, and biomedical innovation.   Through annual scientific meetings, educational programs, and international collaboration, KSAAE fosters dialogue among researchers, industry professionals, policymakers, and regulatory bodies.   The society is committed to accelerating the adoption of New Approach Methodologies (NAMs) and supporting the transition toward more human-relevant, ethical, and scientifically advanced testing strategies.  
썸네일
The 52nd Annual Meeting of the Japanese Society of Toxicology (JSOT). NEXEL is heading to the JSOT 2025 Annual Meeting in Okinawa, Japan!   The Japanese Society of Toxicology (JSOT) has been a driving force in advancing toxicological sciences across Asia. This year’s theme: “Diversity in Toxicological Sciences for Sustainable Environments and Human Health.”   As a global leader in iPSC-based technologies and next-gen non-clinical testing, NEXEL will showcase: Human iPSC-derived cell products Cardio-safety analysis platforms Custom CDMO & assay development services   We're accelerating the transition to animal-free, human-relevant models—enabling safer, more ethical, and predictive toxicology.   Meet us at Booth #70 & #91 to explore how NEXEL’s innovative solutions can drive your next breakthrough! ≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡   The JSOT, which celebrates its 50th anniversary in 2023, has contributed greatly to the development of toxicological sciences, together with the Society of Toxicology (SOT) and the European Society of Toxicology.   In particular, in 1994, in cooperation with the Korean Society of Toxicology (KSOT), the JSOT established the Asian Society of Toxicology (ASIATOX) which includes the Chinese Society of Toxicology, the Thai Society of Toxicology, and the Toxicology Society of Taiwan.   Currently, JSOT is bringing together eight organizations and aggressively pursuing activities as a leader in Asia.   The theme of this annual meeting is "Diversity in Toxicological Sciences for Sustainable Environments and Human Health" We aim to provide an international annual meeting where domestic toxicological research scientists can meet with toxicological research scientists from SOT and ASIATOX, and where the latest information in the toxicological sciences can be collected and opinions can be actively exchanged.  
썸네일
Bio International Convention 2025 in Boston, USA.   NEXEL is heading to BIO International Convention 2025 in Boston, USA!   Join us at the world’s largest biotech event, where 20,000+ industry leaders come together to shape the future of science, medicine, and sustainability.   As a pioneer in iPSC-based technologies and next-gen non-clinical testing, NEXEL will showcase: - iPSC-derived cell products - Cardio-safety analysis services - Customized CDMO solutions   We’re redefining drug discovery with human-relevant, animal-free models—enabling safer, faster, and more ethical innovation.   We’ll be at Booth #2182—visit us to explore how NEXEL’s innovative technologies can drive your next breakthrough and foster impactful collaborations.   ≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡   The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.   In a time of remarkable discovery and progress, the biotechnology industry stands at the forefront of a revolution changing how we live, heal, and care.   From pioneering treatments offering hope to millions, to sustainable agricultural innovations to feed a growing population, or environmental breakthroughs securing our future, biotech drives positive change faster than ever.   This progress is not just a change but a promise for a brighter future.   The world is ready.   Whether you work at a public pharmaceutical company, biotech startup, academia, non-profit organization, or government agency; or you work as a researcher, business development professional or investor, BIO is where you'll make valuable connections and build relationships.   Our proprietary BIO Partnering™ match-making platform—exclusive to the Premier Access registration package—allows you to find potential partners, schedule and accept meetings.  
썸네일
The 47th Workshop of The Korean Society of Non-Clinical Study (KSNS). NEXEL is excited to attend the upcoming Korean Society of Non-Clinical Study (KSNS) meeting in Korea, Suwon!   As a leader in iPSC-based technologies and next-generation non-clinical testing methods, we’re looking forward to joining fellow researchers and industry experts to share insights and spark new ideas.   At KSNS, we’ll be showcasing our portfolio of iPSC-derived cell products, cardio-safety analysis services, and customized CDMO solutions to support more predictive and human-relevant research models.   If you’re attending KSNS, we’d love to connect with you!   Let’s explore how our technologies can contribute to your research and development goals.   ≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡   The central theme of this year’s 20th anniversary symposium is “Aging.” While aging is an inevitable fate for all living organisms, aging gracefully and healthily is a universal aspiration. The question we face is: how can we bring this beautiful journey to a meaningful close?   In pursuit of an answer, the first session will explore new opportunities within the full-cycle regenerative medicine R&D support program. We will also share recent advancements in therapeutics for cachexia and sarcopenia, and discuss innovative treatment strategies. The thematic session on cutting-edge drug development will highlight emerging research and technology trends, including targeted protein degradation (TPD), antibody-drug conjugates (ADCs), theranostic radiopharmaceuticals, therapeutic peptides, and the latest developments in xenobiotic analysis. In addition, we will address key areas in pharmacokinetics and toxicology, such as microbiome mouse models, and cardiotoxicity and neurotoxicity studies.   This year’s workshop will also feature a special local session focused on gene and cell therapy, showcasing research on safety and efficacy as well as advances in target safety assessment technologies. Attendees will gain insights into the latest trends shaping the field. The final session will examine the current status and future outlook of obesity and Alzheimer’s treatments, offering a broader perspective on the direction and potential of next-generation drug development.  
썸네일
Korean BioChip Society (KBCS) 2025 Conference..   Nexel will be attending the Korean BioChip Society (KBCS) 2025 Conference!   We’re excited to join this dynamic community of researchers and innovators in biochip and biosensor technologies.   At KBCS, we’ll be showcasing our iPSC-derived cell products, cardio-safety analysis services, and iPSC manufacturing CDMO solutions.   Visit us at booth #16 to discover how our technologies can support your research and development goals.   If you’ll be there, we’d love to connect and explore opportunities to collaborate!   ≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡   The 2025 Korean BioChip Society (KBCS) Spring Conference is a premier academic event that brings together over 1,000 experts in biosensors, protein chips, DNA chips, bio-MEMS, biomedical devices, diagnostics, and biomedical research.   The conference serves as a platform for sharing the latest research achievements and advancements in the field of biochip technology.
썸네일
ISCT Global Regulators Summit 2025: Optimizing Accelerated Pathways to Fast-Track Product Approvals.   Nexel will be attending ISCT 2025 in New Orleans, USA! This year, we're excited to be collaborating with AMS Bio at booth #915. Stop by to learn more about our iPSC-derived cell products, cardio-safety analysis services, and iPSC manufacturing CDMO service. We’d love to connect and explore opportunities to collaborate! ≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡ ISCT Global Regulators Summit *Optimizing Accelerated Pathways to Fast-Track Product Approvals The 3rd Annual Global Regulators Summit will bring together representatives from international regulatory organizations to jointly address and enhance accelerated regulatory pathways for cell and gene therapy products. The discussion will focus on the evolving regulatory landscape, challenges, and the future directions for accelerated pathways. The summit will address: 1. Review current accelerated pathways that are in place for approval of cell and gene therapy products 2. Examine the key challenges faced by the regulatory agencies in ensuring that these pathways truly accelerate product approval timelines without compromising safety and efficacy 3. Identify specific areas for enhancing the effectiveness and post-approval validation of expedited regulatory pathways
썸네일
BIO KOREA 2025.   Nexel will be participating in BIO KOREA, taking place in Seoul, Korea!   We’d love to welcome you at booth #B22 to learn more about our  iPSC derived cell products, cardiosafety analysis svc, and iPSC manufacturing CDMO svc.   You’ll also get a chance to check out the Mantarray platform — a cutting-edge system for 3D tissue contractility analysis that delivers clinically relevant functional data. Don’t miss the opportunity to see it in action!   ≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡≡   BIO KOREA 2025   BIO KOREA conference where experts and world-class scholars from the biohealth industry participate every year!   The conference provides a platform for exchanging the latest industry trends and engaging in discussions.   May 7 (Wed) ~ 9 (Fri), 2025 / Conference Room (3, 4F), COEX, SEOUL  
  1. 1
  2. 2
  3. 3
  4. 4
Beyond conventional boundaries,
we deliver a bold new paradigm.

  • iPSC technologyCONTACT

    Contact Information

    • 주소: 서울시 강서구 마곡동로 55, 8층(07802)

    • 사업자등록번호: 109-86-37282
    • 대표자: Choongseong Han

    • 대표번호 : 02-2088-8886
    • 팩스번호: 02-2088-8884
    • 이메일 : support@nexel.co.kr